ClinConnect ClinConnect Logo
Search / Trial NCT06172907

A Dyadic Intervention for Young Adult Patients with Cancer and Their Partner Caregivers

Launched by MASSACHUSETTS GENERAL HOSPITAL · Dec 7, 2023

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Young Adult Cancer Cancer Caregiving

ClinConnect Summary

This clinical trial is exploring a new type of short therapy designed to help young adults with cancer and their partners cope better with the emotional challenges that come with a cancer diagnosis. The study aims to see if this therapy can improve how they handle stress and strengthen their relationship during this difficult time. The trial is currently looking for participants aged 25 to 39 who are either undergoing cancer treatment or have finished treatment within the past two years, as well as their partners.

To be eligible, participants should have some level of psychological distress, which means they might be feeling anxious or overwhelmed due to the cancer experience. The trial is taking place at Massachusetts General Cancer Center in Boston, and it welcomes all genders. Participants will be involved in therapy sessions designed to address their unique needs, and the researchers hope to learn how well this approach works for both the patients and their caregivers. It's important to note that individuals with severe mental health issues, like uncontrolled psychosis or suicidal thoughts, are not eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Either: (1) Currently receiving active cancer treatment (n=5) or are within two years of completing active treatment (n=5) at Massachusetts General Cancer Center (MGHCC), located in Boston, Massachusetts, United States, OR (2) are the partner of an individual between the ages of 25-39 who is currently receiving treatment at MGHCC (n=5) or who has completed cancer treatment at MGHCC within the past two years (n=5)
  • Either: (1) Indicates a score ≥4 on the National Comprehensive Cancer Network (NCCN) adapted distress thermometer study screening questions, OR (2) are the partner of a participant indicating a score ≥4 on the NCCN adapted distress thermometer study screening questions
  • English-speaking
  • Exclusion Criteria:
  • • Uncontrolled psychosis, active suicidal ideation, or cognitive impairment

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Concord, Massachusetts, United States

Danvers, Massachusetts, United States

Newton, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Jamie M Jacobs, Ph.D.

Principal Investigator

Massachusetts General Hospital

Giselle K Perez, Ph.D.

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported